Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Advancements: Q1 2025 Report

AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.

Business Development / Digital Health / Supply Chain

Accelerating Healthcare Solutions with B2B eCommerce

EPAM recently published a case study highlighting the rise of composable commerce solutions to enable B2B processes in the healthcare industry. This piece focuses on the experience of diagnostics company,…

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Equity / Legal / Regulatory Affairs / Small Business

The Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

A document titled "The Impact of Tariffs on Patient Access to Medical Technology" features sections discussing the importance of the medtech industry and the negative effects of import tariffs on healthcare costs, supply chains, and patient access. The document is formatted with bullet points and bolded key terms
Coverage & Payment / Emerging Policy Response Resources / Global & Trade / Supply Chain / Tariffs

The Impact of Tariffs on Patient Access to Medical Technology

Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.

Tablet displaying cover of AdvaMed®'s "Annual Report: 2024 Year in Review" with a blue abstract background.

2024 Annual Report

Explore AdvaMed®’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.